SELECTBIO Conferences Advances in Drug Discovery
 
Advances in Drug Discovery 2017
Venue: Wellcome Genome Campus, Hinxton, Cambridge, UK
Date: 6 - 7 March, 2017

Keynote Speakers

Stefan Knapp

Stefan Knapp
Professor, Goethe Institut Franfurt

Dafydd Owen

Dafydd Owen
Associate Research Fellow, Pfizer Ltd

Sally Ward

Sally Ward
Professor, Texas A&M Health Science Center

Danica Fujimori

Danica Fujimori
Principal Investigator, University of California San Francisco

Paul Workman

Paul Workman
Chief Executive and President, Institute of Cancer Research, London

Michelle Arkin

Michelle Arkin
Director, University of California San Francisco

James Audia

James Audia
Chief Scientific Officer, Constellation Pharmaceuticals

Rakesh Dixit

Rakesh Dixit
Vice President/Global Head, MedImmune Inc

Christine Mummery

Christine Mummery
Professor and Chair of Developmental Biology, Leiden University Medical Centre

Ludovic Vallier

Ludovic Vallier
Professor, University Of Cambridge

Sir Alan Fersht

Sir Alan Fersht
Professor, MRC Laboratory of Molecular Biology

View all

Overview

SELECTBIO is pleased to announce that Advances in Drug Discovery will be taking place at Wellcome Genome Campus, Hinxton, Cambridge on 6 - 7 March, 2017. 

Building on the success of our Cambridge Workshop Series, this conference will feature four tracks:
As a multi-track event, delegates will have unrestricted access to all conference tracks and networking opportunities.  




Exhibition Sponsors Media Sponsors Networking
U-Networks